Addex Therapeutics LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Lenaic Nathanael Teyssedou, PRINCIPAL ACCOUNTING OFFICER of Addex Therapeutics Ltd., reported multiple transactions in common stock on September 2, 2026.
NASDAQ
Mikhail Kalinichev, HEAD OF TRANSLATIONAL SCIENCE of Addex Therapeutics Ltd., reported multiple transactions in common stock on September 2, 2026.
NASDAQ
Jason Raleigh Nunn, a Director of Addex Therapeutics Ltd., reported multiple transactions in common stock on September 2, 2026.
NASDAQ
Isaac Manke, a Director of Addex Therapeutics Ltd., reported multiple transactions in common stock on September 2, 2026.
NASDAQ
Vincent Michael Lawton, a Director of Addex Therapeutics Ltd., reported multiple transactions in common stock on September 2, 2026.
NASDAQ
Timothy Mark Dyer, CHIEF EXECUTIVE OFFICER and a Director of Addex Therapeutics Ltd., reported multiple transactions in common stock on September 2, 2026.